IGF1 and amyotrophic lateral sclerosis: In this work, we compared the effects of treating a SOD1G93A ALS mouse model with repeated weekly treatments of US alone or US IGF1 and assessed the impact on survival as well as histological markers and molecular profiles of glial and immune cells.